This session will focus on how mobility is changing the life sciences commercial platform landscape – there is a rush to adapt iPads within the field, but what additional value can they bring to customers and how do they fit into an overall sales enablement platform strategy? Should life sciences companies make significant investments and establish leadership positions now in mobile technology platforms and services? For those that have made the investment, how do you maximize your investment? This session will examine the obstacles and provide examples of business models that are emerging around the world and describe how innovation is being evaluated and adopted. Discussion will include reimbursement models, current clinical evidence, emerging mHealth standards and business models enabling a return on investment for all participants and where to look for innovation.